Skip to content
Lower risk Drug recall · FDA · Published September 12, 2025

JB Chemicals recalls Cetirizine 10mg tablets with wrong ID imprint

JB Chemicals recalls 100-tablet Cetirizine Hydrochloride 10mg bottles due to incorrect labeling. Consumers should check for wrong ID imprint on tablets.

🇺🇸 FDA recall #D-0032-2026DrugJB Chemicals ›
Take action

Contact the company

Recalling firmJB Chemicals and Pharmaceuticals LtdNeelam Centre A Wing A B Wing, 4th Floor; Hind Cycle Road · Mumbai, India
✎ GovInfoNow plain-language explainer

JB Chemicals is recalling 100-tablet Cetirizine Hydrochloride 10mg bottles because they have the wrong ID imprint. This could lead to confusion about which medication is being taken, potentially causing incorrect dosing. Read more at govinfonow.com/recall/31787-jb-chemicals-recalls-cetirizine-10mg-tablets-with-wrong-id-imprint.

Source Summary by GovInfoNow · govinfonow.com/recall/31787-jb-chemicals-recalls-cetirizine-10mg-tablets-with-wrong-id-imprint · Updated August 17, 2026 · FDA enforcement record: FDA #D-0032-2026

Cite this page

“JB Chemicals recalls Cetirizine 10mg tablets with wrong ID imprint.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31787-jb-chemicals-recalls-cetirizine-10mg-tablets-with-wrong-id-imprint. Based on FDA recall #D-0032-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0032-2026%22&limit=1).

The FDA announced on Sept. 12, 2025, that JB Chemicals and Pharmaceuticals Ltd is recalling Cetirizine Hydrochloride Tablets USP 10 mg due to tablets being imprinted with the wrong identification code. The recall affects 9,936 bottles distributed nationwide.

How to tell if you have it

  • Brand: JB Chemicals
  • Product: Cetirizine Hydrochloride Tablets USP 10 mg, 100 Tablets bottles
  • Manufacturer: Unique Pharmaceuticals Labs (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.)
  • Distributor: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816
  • NDC: 16571-402-10
  • Lot #: PY925014A
  • Expiration: 1/31/2028
  • Quantity: 9,936 bottles

The hazard

The tablets are imprinted with the wrong identification code. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show JB Chemicals and Pharmaceuticals Ltd has two other recalls on record since April 23, 2026. On June 24, 2026, the brand recalled Cetirizine Tablets due to cross-contamination with Ranitidine. Other recent recalls of similar products include Unichem's Doxazosin 4mg Tablets recall (Jan. 21, 2026), American Regent's Levocarnitine Injection recall (April 16, 2026), and Synjardy XR Tablets recall (June 12, 2026).

How to tell if you have this one

Check for the lot number PY925014A on the bottle. The product was distributed by Rising Pharma Holdings, Inc. in the United States with the NDC 16571-402-10.

  • Brand
    JB Chemicals
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Ongoing
  • Distribution
    U.S. Nationwide
  • NDC
    16571-402-10, 16571-402-30, 16571-402-50
Recall numberProduct, codes & lotsQuantity
D-0032-2026Cetirizine Hydrochloride Tablets USP 10 mg, 100 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-10.; Lot # PY925014A; Exp. 1/31/20289936 bottles
D-0033-2026Cetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-402-50; Lot # PY925014, PY925013, Exp. 1/31/202813,440 bottles
Based on the official FDA remedy

What to do — step by step

  1. Check for Wrong ID Imprint

    Look for incorrect labeling on the tablet bottle, specifically the lot number PY925014A.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 47 days after the firm started it.

1. Firm started the recall: Sep 12, 202512. FDA classified it Class III: Oct 17, 202523. Published in FDA’s Enforcement Report: Oct 29, 202532025
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall is due to a wrong ID imprint, not a safety issue. The product is safe to use if the correct label is present.

What should I do if I have the recalled product?

The recall does not require immediate action. Check for the wrong ID imprint and contact the manufacturer if you have concerns.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0032-2026 (September 12, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0032-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA